San Diego, CA
Kate Therapeutics is a patient-focused biotechnology company developing AAV-based gene therapies to treat genetically defined muscle and heart diseases.
katetherapeutics.comThese are collections Kate Therapeutics is a part of. Click on the collection name to view similar companies.
Series B
$21,775,022
Series A
$51,000,000
0 out of 5 stars
Based on 0 reviews
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Kate Therapeutics.